Andrew Kenneth William Powell - Jun 10, 2022 Form 4 Insider Report for Silverback Therapeutics, Inc. (SPRY)

Role
Director
Signature
/s/ Jeffrey C. Pepe, Attorney-in-Fact
Stock symbol
SPRY
Transactions as of
Jun 10, 2022
Transactions value $
$0
Form type
4
Date filed
6/13/2022, 07:44 PM
Previous filing
Jun 7, 2022
Next filing
Jan 20, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SPRY Stock Option (right to buy) Award $0 +18K $0.00 18K Jun 10, 2022 Common Stock 18K $4.18 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to the option vest on the earlier of June 10, 2023 or the date of the Issuer's 2023 annual meeting of stockholders, which date has not been set by the Issuer's Board of Directors.